Purchase Order 140D0425P0205
Award Date 9/16/25
Potential Completion Date 9/19/28
Potential Value $740K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This task order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The task order, valued at $131,421.00, is for analytical method development and validation, characterization, and stability studies of the drug substance ML-246 under the parent contract "CRO Support for NCATS Drug Substance Development and Manufacture." The...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $92,605 firm fixed price delivery order to Mriglobal, doing business as Midwest Research Institute, an independent not-for-profit research organization. The order is part of the $100 million IDIQ contract vehicle from HHS ASPR to maintain nonclinical laboratory networks evaluating medical countermeasures. This delivery order is for ML-246 (METARRESTIN)...
- This is a $99,500.00 delivery order contract awarded to Mriglobal, also doing business as Midwest Research Institute, by the Department of Health and Human Services' National Institutes of Health National Institute on Aging. The contract is for drug toxicity testing services, with a period of performance through July 31, 2024. The contract is not set aside for any small business program. Mriglobal is a 501(c)(3) non-profit research organization that specializes in scientific research, testing,...
- This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute to Mriglobal, a 501(c)(3) not-for-profit research organization based in Kansas City, Missouri. The contract, valued at $1,658,742.83, is for drug shelf life testing services. The contract does not have a set-aside designation. Mriglobal has significant experience as a prime contractor for the federal government, holding multiple Indefinite Delivery Vehicles (IDVs) with various agencies such as the National...
- This is a $4,415,116.56 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Mriglobal, doing business as Midwest Research Institute, to provide shelf life evaluation of investigational dosage forms. The contract does not have a small business set-aside designation. Mriglobal is an independent, not-for-profit research organization that conducts over $110 million in research annually for federal and commercial...
- This is a $5,108,214.00 cost-plus-award-fee delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) with an ultimate completion date of September 18, 2029. Mriglobal has been awarded multiple significant federal contracts and grants, including Indefinite Delivery Contracts...
- This is a delivery order federal contract awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $1,524,929.00 contract is for the manufacture of plasmid DNA drug substance and drug product. The period of performance runs through September 24, 2027. Mriglobal has been awarded multiple significant federal contracts and grants...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a non-profit research organization. The contract is valued at $949,295.00 and will run through January 31, 2026. The contract is for the evaluation of the shelf-life of samples of investigational clinical drug formulations, including parenteral, oral, and other dosage...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $1,596,279.92 cost-plus-fixed-fee delivery order contract to Midwest Research Institute (doing business as Mriglobal), a not-for-profit research organization, under the Drug Manufacturing and Formulation Program (DMFP) indefinite delivery/indefinite quantity (IDIQ) contract. The contract does not have a set-aside designation. Key subcontractors include the University...
- This is a $26,932,208.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is for a Centralized Chemopreventive Agent Repository and Chemistry Support and has an ultimate completion date of June 30, 2028. Mriglobal is the prime contractor and there is no set-aside designation indicated. The contract appears to be part of...